WO1998026738A1 - Device for the treatment of infarcted tissue and method of using the device - Google Patents
Device for the treatment of infarcted tissue and method of using the device Download PDFInfo
- Publication number
- WO1998026738A1 WO1998026738A1 PCT/US1997/022140 US9722140W WO9826738A1 WO 1998026738 A1 WO1998026738 A1 WO 1998026738A1 US 9722140 W US9722140 W US 9722140W WO 9826738 A1 WO9826738 A1 WO 9826738A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- scar
- heating element
- infarct
- squeezing
- heating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
- A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/148—Probes or electrodes therefor having a short, rigid shaft for accessing the inner body transcutaneously, e.g. for neurosurgery or arthroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1442—Probes having pivoting end effectors, e.g. forceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1482—Probes or electrodes therefor having a long rigid shaft for accessing the inner body transcutaneously in minimal invasive surgery, e.g. laparoscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00115—Electrical control of surgical instruments with audible or visual output
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00666—Sensing and controlling the application of energy using a threshold value
Definitions
- the present invention is related generally to the modification of heart tissue for the treatment of myocardial infarction.
- the heart has four chambers for receiving and pumping blood to various parts of the body.
- oxygen- poor blood returning from the body enters the right atrium.
- the right atrium fills with blood and eventually contracts to expel the blood through the tricuspid valve to the right ventricle.
- Contraction of the right ventricle ejects the blood in a pulse-like manner into the pulmonary artery and each lung.
- the oxygenated blood leaves the lungs through the pulmonary veins and fills the left atrium.
- the left atrium fills with blood and eventually contracts to expel the blood through the mitral valve to the left ventricle.
- Contraction of the left ventricle forces blood through the aorta to eventually deliver the oxygenated blood to the rest of the body.
- Myocardial infarction i.e. , heart attack
- Congestive heart failure is a condition wherein the heart can not pump enough blood.
- part of the circulation to the heart wall muscle is lost usually do to a blood clot which dislodges from a larger artery and obstructs a coronary artery. If the clot is not dissolved within about 3 to 4 hours, the muscle which lost its blood supply necroses and subsequently becomes a scar.
- the scarred muscle is not contractile, therefore it does not contribute, to the pumping ability of the heart.
- the scarred muscle is elastic (i.e. , floppy) which further reduces the efficiency of the heart because a portion of the force created by the remaining healthy muscle bulges out the scarred tissue (i.e.
- ventricular aneurysm instead of pumping the blood out of the heart.
- Congestive heart failure is generally treated with lots of rest, a low-salt diet, and medications such as A.C.E. inhibitors, digitalis, vasodilators and diuretics.
- the scarred muscle is cut out of the heart and the remaining portions of the heart are sutured (i.e. , aneurysmectomy).
- a heart transplant may be performed.
- Collagen-containing tissue is ubiquitous in the human body and makes up a substantial portion of the scar. Collagen demonstrates several unique characteristics not found in other tissues. Intermolecular cross links provide collagen-containing tissue with unique physical properties of high tensile strength and substantial elasticity.
- a property of collagen is shrinkage of collagen fibers when elevated in temperature. This molecular response to temperature elevation is believed to be the result of rupture of the collagen stabilizing cross links and immediate contraction of the collagen fibers to about one-third of their original linear dimension or the result of a change in the hydration of the tissue.
- Another property of collagen is that the caliber of the individual fibers increases greatly, over four fold, without changing the structural integrity of the connective tissue.
- Thermal destruction (i.e. , ablation) of problematic myocardial tissue is a therapeutic procedure used with increasing frequency for the treatment of cardiac arrhythmias (e.g. , ventricular tachycardia) as described in U.S. Patent No. 5,246,438.
- the treatment of cardiac arrhythmias involves treating electrically problematic but otherwise healthy tissue.
- one goal of ablation is to localize the heat as much as possible so as to restrict the ablation to only the problematic healthy tissue.
- the present invention provides a device and method for treating infarct scar tissue of a mammalian heart by selectively heating the infarct scar to reduce the size of the scar tissue surface area, increase the cross-section of the scar tissue, stiffen the floppy portion of the scar tissue, reduce the ventricular systolic wall tension, and increase the overall pumping efficiency of the infarcted heart by eliminating the ventricular aneurysm, if present.
- the present invention preferably does not affect the healthy heart tissue or ablate the infarcted tissue.
- the present invention diffuses the heat over the infarcted area.
- the method is similar to an annealing process wherein the scar tissue undergoes heating and then is allowed to cool slowly.
- the heat can be applied to or induced in the infarct scar. Force can also be applied in accordance with the present invention to assist the reduction of the size of the scar. Generally speaking, besides reducing the surface area of the scarred tissue, the present invention alters the material properties of the infarct scar such as making it stiffer and less elastic.
- an apparatus for heating an infarct scar in a heart having a heating element having a projection for piercing the scar and a mechanism for squeezing at least two portions of the scar toward each other.
- a method for treating an infarct scar in a heart including the step of energizing a heating element to raise the temperature of the infarct scar to a temperature sufficient to reduce the surface area of the infarct scar.
- a method for training a person to perform a method for treating an infarct scar in a heart including the steps of demonstrating or instructing how to do the following step of energizing a heating element to raise the temperature of the infarct scar to a temperature sufficient to reduce the surface area of the infarct scar.
- a modified mammalian heart having a contracted infarct scar tissue portion diminished in its surface area and stiffened.
- a method for treating an infarct scar in a heart including the step of energizing a heating element to raise the temperature of the infarct scar to a temperature sufficient to reduce the ventricular systolic wall tension.
- FIG. 1 is a mammalian heart with electrodes inserted in an infarcted area
- FIG. 2 is a mammalian heart with a radio-frequency heating element in contact with the infarcted area;
- FIG. 3 is a front view of a device for heating and squeezing portions of the infarcted area together;
- FIG. 4 is a side view of the device of FIG. 3; and FIG. 5 is a top view of the device of FIG. 2 during treatment of the infarcted area.
- the present invention provides a device and method for altering the material properties of collagen-containing infarcted tissue in a patient's heart.
- a method of training a person to perform a method for treating an infarct scar in a mammalian heart is used to accurately control the inducement of heat or application of heat within a specific thermal range, and deliver thermal energy to the collagen-containing infarcted tissue to reduce the size of the scar tissue area by shrinking the infarcted tissue in the heart and stiffening the floppy portion of the scar tissue without ablating the tissue.
- the overall pumping efficiency of the infarcted heart is increased.
- a modified mammalian heart having a contracted infarct scar tissue portion diminished in its surface area and reduced ventricular systolic wall tension results.
- FIG. 1 there is illustrated a heart 10 having an infarcted region or portion 12.
- the infarcted portion 12 of the heart can be accessed with conventional open chest surgery or with arthroscopic techniques.
- a positive electrode 14 and negative electrode 16 are inserted in a portion of the infarcted portion 12 to induce resistive heating in the infarct scar in the desired treatment area 18 when energy is applied across the electrodes.
- the positive and negative electrodes can be placed in contact with the infarcted scar.
- the positive and negative electrodes function as a heating element as they are energized to raise the temperature of the scar in the desired treatment area 18 to a temperature sufficient to reduce the surface area of the scar without ablating the scar tissue or damaging the healthy tissue surrounding the infarcted portion 12.
- heating element encompasses elements that apply energy thereby inducing heat in the tissue as well as to elements that apply heat to the tissue.
- the scar is heated to a temperature in the range of about 40 degrees Celsius to about 75 degrees Celsius, more preferably about 60 degrees Celsius to about 65 degrees Celsius.
- the desired treatment area 18 After the desired treatment area 18 has been heated, it is allowed to cool. Energy is no longer applied after there has been sufficient shrinkage of the scar tissue. Sufficient shrinkage may be detected visually, mechanically, echocardiograhically, ventriculographically with x-ray, fluoroscopically or with appropriate feed back variables, such as impedance monitoring, temperature monitoring, or any other suitable method.
- the electrodes or heating element can then be moved to another portion of the infarcted portion 12 for treatment. It is believed, without being limited to a particular theory, that as the infarct scar is heated the collagen fibers straighten then as the collagen fibers cool they re-entwine or refold around each other becoming shorter, tighter, thicker, stronger, stiffer, or some combination of these qualities.
- the method is contemplated to be used with any suitable appliance for applying radiant energy, thermal energy, or to otherwise heat the infarcted tissue and reduce the area of the infarcted tissue.
- a radio-frequency generator 20 and heating element applicator 22 can be used (FIG. 2).
- the radio-frequency generator 20 When the heating element 24 of the applicator 22 is positioned at the desired treatment site, the radio-frequency generator 20 is activated to provide suitable energy, preferably at a selected frequency in the range of 10 megahertz to 1000 megahertz, to heat the scar tissue to a temperature sufficient to reduce the surface area of the scar without ablating the scar tissue or damaging the healthy tissue surrounding the infarcted area 12.
- the emitted energy is converted within the scar tissue into heat in the range of about 40 degrees Celsius to about 75 degrees Celsius, more preferably in the range of about 60 degrees Celsius to about 65 degrees Celsius.
- the radio-frequency energy is preferably applied at low power levels (e.g. , 1 to 20 watts). Suitable radio-frequency power sources are readily commercially available.
- the radio- frequency generator 20 has a single channel, delivering approximately 1 to 20 watts of energy and possessing continuous delivery capability.
- the heating element 24 of the applicator 22, as shown in FIG. 2, operates as a unipolar electrode.
- An outer electrode (not shown) having a much larger surface area than the heating element 24 is placed on the outer surface of the patient's body.
- an external metal mesh or solid plate is placed on the skin.
- Both electrodes are connected to radio-frequency generator 20 which produces an electric field at a high frequency within the patient's body. Because the surface area of the heating element 24 is much smaller than that of the outer electrode, the density of the high frequency electric field is much higher around the heating element. The electric field reaches its highest density between the two electrodes in the region near the heating element 24. The increased density of the field around the heating element 24 produces localized heating of the scar tissue in the treatment area 18.
- two electrodes can be placed on the scar and energized in a bipolar fashion.
- FIGS. 3-5 another embodiment for a heating device is shown.
- the heating device of FIGS. 3-5 is comprised of a scissor-like clamp 26 having crossing arms 28 and 30 which are connected by pin 32 near the mid-point of the arms.
- arms 28 and 30 are handles 34 and 36, respectively, and at their distal ends 38 and 40, respectively, a plurality of protrusions 42 spaced along elongated members 44 and 46, respectively.
- An optional releasable lock 48 is located between arms 28 and 30.
- an optional fixed force spring can be located between the arms.
- Attached to arm 28 is a positive electrode 50 and attached to arm 30 is negative electrode 52.
- Each of the arms 28 and 30 are free to rotate about pin 32 and are electrically isolated from each other such that when a potential is applied between the electrodes 50 and 52 there is no short between the arms.
- the clamp 26 is used by a surgeon (or an individual demonstrating) to squeeze and shrink a portion of the area of the infarct scar tissue 12. (Likewise, an individual can instruct a surgeon on how to accomplish the method of the present invention with the clamp 26 or other embodiments disclosed herein.)
- the surgeon grabs (or pierces the scar tissue with the protrusions 42, if present) and squeezes the two portions of the scar tissue toward each other by actuating the clamp with the handles 34 and 36 (FIG. 5).
- the protrusions 42 when present are conductive elements.
- the positive and negative electrodes are then energized by the surgeon to function as a heating element to raise the temperature of the scar in the desired treatment area 18 to a temperature sufficient to reduce the surface area of the scar without ablating the scar tissue or damaging the healthy tissue surrounding the infarcted portion 12.
- the protrusions can be used to treat endocardial, sub-endocardial and transmural infarcted areas.
- the protrusions can have insulated proximal portions such that the distal portions are used to treat endocardial infarcted areas.
- the protrusions can have insulated distal portions such that the proximal portions are used to treat sub- endocardial infarcted areas.
- the protrusions can be uninsulated to treat transmural infarcted areas.
- the clamp 26 is beneficial in applying force to the infarcted tissue to assist in the shrinking process.
- the releasable lock 48 or fixed force spring can be used to preset the distance which the two portions of the scar are going to be moved toward each other. Alternatively, the releasable lock can be used to hold the two portions steady at a given distance during the heating process.
- the elongated members 44 and 46 are generally not brought close together so that a larger area of the scar can be treated. Generally, the elongated members 44 and 46 are actuated toward each other so as to apply a relatively small amount of force to assist the shrinking process.
- the clamp 26 illustrated in FIGS. 3-5 utilizes resistive heating of the scar tissue, but it is also within the scope of the invention that a radio-frequency generator and electrodes, as well as other means to be described below, can be utilized.
- the heating element of any of the embodiments can be made to provide protection against overheating of the scar tissue.
- Techniques for example temperature monitoring or electrical characteristic monitoring (e.g. , impedance), can be utilized in a system which shuts down the application of energy to the heating element to avoid ablating the tissue or damaging healthy tissue.
- the surgeon can, if desired, override the feedback control system.
- a microprocessor can be included and incorporated into the feedback control system to switch the power on and off, as well as modulate the power.
- the microprocessor can serve as a controller to watch the temperature and modulate the power in order to avoid over-heating of the tissue.
- the heating element can be synchronized with the ECG so that the heart wall is in diastole.
- the system can include auditory or visual feedback indicators for signalling when shrinkage, temperature, or other variables are occurring and also when any have reached or exceeded desired conditions.
- Heating element 42 in accordance with any of the embodiments can be a number of different materials including but not limited to conductive polymer, stainless steel, platinum, or other noble metals.
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002275688A CA2275688A1 (en) | 1996-12-08 | 1997-12-12 | Device for the treatment of infarcted tissue and method of using the device |
BR9714947-0A BR9714947A (en) | 1996-12-08 | 1997-12-12 | Apparatus for the treatment of infarcted tissue and method of using the apparatus |
EP97954042A EP0963185A4 (en) | 1996-12-08 | 1997-12-12 | Device for the treatment of infarcted tissue and method of using the device |
AU57920/98A AU5792098A (en) | 1996-12-08 | 1997-12-12 | Device for the treatment of infarcted tissue and method of using the device |
JP52775798A JP2002515795A (en) | 1996-12-08 | 1997-12-12 | Device for treating infarcted tissue and treatment method using the device |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/768,607 US6071303A (en) | 1996-12-08 | 1996-12-08 | Device for the treatment of infarcted tissue and method of treating infarcted tissue |
US08/768,607 | 1996-12-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998026738A1 true WO1998026738A1 (en) | 1998-06-25 |
Family
ID=25082974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/022140 WO1998026738A1 (en) | 1996-12-08 | 1997-12-12 | Device for the treatment of infarcted tissue and method of using the device |
Country Status (7)
Country | Link |
---|---|
US (1) | US6071303A (en) |
EP (1) | EP0963185A4 (en) |
JP (1) | JP2002515795A (en) |
AU (1) | AU5792098A (en) |
BR (1) | BR9714947A (en) |
CA (1) | CA2275688A1 (en) |
WO (1) | WO1998026738A1 (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6045497A (en) * | 1997-01-02 | 2000-04-04 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US6050936A (en) * | 1997-01-02 | 2000-04-18 | Myocor, Inc. | Heart wall tension reduction apparatus |
US6183411B1 (en) | 1998-09-21 | 2001-02-06 | Myocor, Inc. | External stress reduction device and method |
US6260552B1 (en) | 1998-07-29 | 2001-07-17 | Myocor, Inc. | Transventricular implant tools and devices |
US6264602B1 (en) | 1998-07-29 | 2001-07-24 | Myocor, Inc. | Stress reduction apparatus and method |
US6332893B1 (en) | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
US6343605B1 (en) | 2000-08-08 | 2002-02-05 | Scimed Life Systems, Inc. | Percutaneous transluminal myocardial implantation device and method |
US6355030B1 (en) | 1998-09-25 | 2002-03-12 | Cardiothoracic Systems, Inc. | Instruments and methods employing thermal energy for the repair and replacement of cardiac valves |
US6406420B1 (en) | 1997-01-02 | 2002-06-18 | Myocor, Inc. | Methods and devices for improving cardiac function in hearts |
US6622730B2 (en) | 2001-03-30 | 2003-09-23 | Myocor, Inc. | Device for marking and aligning positions on the heart |
JP2004512859A (en) * | 2000-04-27 | 2004-04-30 | アトリキュア インコーポレイテッド | Transmural cutting device and method |
US7666224B2 (en) | 2002-11-12 | 2010-02-23 | Edwards Lifesciences Llc | Devices and methods for heart valve treatment |
US7678145B2 (en) | 2002-01-09 | 2010-03-16 | Edwards Lifesciences Llc | Devices and methods for heart valve treatment |
US7766812B2 (en) | 2000-10-06 | 2010-08-03 | Edwards Lifesciences Llc | Methods and devices for improving mitral valve function |
US8092367B2 (en) | 2001-09-07 | 2012-01-10 | Mardil, Inc. | Method for external stabilization of the base of the heart |
US10463886B2 (en) | 2007-02-22 | 2019-11-05 | Ramot At Tel-Aviv University Ltd. | Treating weakened vessel wall such as vulnerable plaque or aneurysms |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6579285B2 (en) * | 1994-09-09 | 2003-06-17 | Cardiofocus, Inc. | Photoablation with infrared radiation |
US20030045771A1 (en) * | 1997-01-02 | 2003-03-06 | Schweich Cyril J. | Heart wall tension reduction devices and methods |
US7883539B2 (en) | 1997-01-02 | 2011-02-08 | Edwards Lifesciences Llc | Heart wall tension reduction apparatus and method |
EP1128769A4 (en) * | 1998-11-06 | 2007-08-01 | Univ Rochester | A method to improve circulation to ischemic tissue |
US8285393B2 (en) * | 1999-04-16 | 2012-10-09 | Laufer Michael D | Device for shaping infarcted heart tissue and method of using the device |
US6702732B1 (en) | 1999-12-22 | 2004-03-09 | Paracor Surgical, Inc. | Expandable cardiac harness for treating congestive heart failure |
CA2402504A1 (en) | 2000-03-10 | 2001-09-20 | Paracor Surgical, Inc. | Expandable cardiac harness for treating congestive heart failure |
US6537198B1 (en) | 2000-03-21 | 2003-03-25 | Myocor, Inc. | Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly |
US6616684B1 (en) * | 2000-10-06 | 2003-09-09 | Myocor, Inc. | Endovascular splinting devices and methods |
US6475179B1 (en) * | 2000-11-10 | 2002-11-05 | New England Medical Center | Tissue folding device for tissue ablation, and method thereof |
WO2002060523A2 (en) | 2000-12-15 | 2002-08-08 | Brown Tony R | Atrial fibrillation rf treatment device and method |
JP2005501652A (en) * | 2001-09-10 | 2005-01-20 | パラコー メディカル インコーポレイテッド | Heart failure treatment device |
EP1446069A1 (en) * | 2001-10-31 | 2004-08-18 | Paracor Surgical, Inc. | Heart failure treatment device |
US7174896B1 (en) | 2002-01-07 | 2007-02-13 | Paracor Medical, Inc. | Method and apparatus for supporting a heart |
US7022063B2 (en) | 2002-01-07 | 2006-04-04 | Paracor Medical, Inc. | Cardiac harness |
US7736299B2 (en) | 2002-11-15 | 2010-06-15 | Paracor Medical, Inc. | Introducer for a cardiac harness delivery |
EP1560541A2 (en) * | 2002-11-15 | 2005-08-10 | Paracor Medical, Inc. | Cardiac harness delivery device |
US8021359B2 (en) | 2003-02-13 | 2011-09-20 | Coaptus Medical Corporation | Transseptal closure of a patent foramen ovale and other cardiac defects |
US7257450B2 (en) | 2003-02-13 | 2007-08-14 | Coaptus Medical Corporation | Systems and methods for securing cardiovascular tissue |
US7044946B2 (en) * | 2003-06-10 | 2006-05-16 | Cryocath Technologies Inc. | Surgical clamp having treatment elements |
US7819860B2 (en) * | 2003-06-10 | 2010-10-26 | Medtronic Cryocath Lp | Surgical clamp having trasmurality assessment capabilities |
US8398632B1 (en) * | 2003-06-10 | 2013-03-19 | Medtronic Cryocath Lp | Surgical clamp having treatment elements |
US7155295B2 (en) * | 2003-11-07 | 2006-12-26 | Paracor Medical, Inc. | Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing |
US7158839B2 (en) * | 2003-11-07 | 2007-01-02 | Paracor Medical, Inc. | Cardiac harness for treating heart disease |
US7473252B2 (en) | 2004-10-07 | 2009-01-06 | Coaptus Medical Corporation | Systems and methods for shrinking and/or securing cardiovascular tissue |
US20070156209A1 (en) * | 2005-01-14 | 2007-07-05 | Co-Repair, Inc. | System for the treatment of heart tissue |
US7455670B2 (en) * | 2005-01-14 | 2008-11-25 | Co-Repair, Inc. | System and method for the treatment of heart tissue |
US20070156210A1 (en) * | 2005-01-14 | 2007-07-05 | Co-Repair, Inc., A California Corporation | Method for the treatment of heart tissue |
WO2008049082A2 (en) | 2006-10-18 | 2008-04-24 | Minnow Medical, Inc. | Inducing desirable temperature effects on body tissue |
US8192351B2 (en) | 2007-08-13 | 2012-06-05 | Paracor Medical, Inc. | Medical device delivery system having integrated introducer |
WO2010054069A1 (en) * | 2008-11-07 | 2010-05-14 | Musc Foundation For Research Development | Devices and methods for treatment of myocardial conditions |
US20100168568A1 (en) * | 2008-12-30 | 2010-07-01 | St. Jude Medical, Atrial Fibrillation Division Inc. | Combined Diagnostic and Therapeutic Device Using Aligned Energy Beams |
US20100324625A1 (en) * | 2009-06-19 | 2010-12-23 | Medtronic, Inc. | Bracketing scar for treating pain with electrical stimulation |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5246438A (en) | 1988-11-25 | 1993-09-21 | Sensor Electronics, Inc. | Method of radiofrequency ablation |
US5323781A (en) * | 1992-01-31 | 1994-06-28 | Duke University | Methods for the diagnosis and ablation treatment of ventricular tachycardia |
US5551427A (en) * | 1995-02-13 | 1996-09-03 | Altman; Peter A. | Implantable device for the effective elimination of cardiac arrhythmogenic sites |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4140130A (en) * | 1977-05-31 | 1979-02-20 | Storm Iii Frederick K | Electrode structure for radio frequency localized heating of tumor bearing tissue |
US4306561A (en) * | 1979-11-05 | 1981-12-22 | Ocean Trading Co., Ltd. | Holding apparatus for repairing severed nerves and method of using the same |
US4854320A (en) * | 1983-10-06 | 1989-08-08 | Laser Surgery Software, Inc. | Laser healing method and apparatus |
US5409479A (en) * | 1983-10-06 | 1995-04-25 | Premier Laser Systems, Inc. | Method for closing tissue wounds using radiative energy beams |
US4620550A (en) * | 1985-04-15 | 1986-11-04 | Schering A.G. | Implantable bipolar stimulating electrode |
US5484432A (en) * | 1985-09-27 | 1996-01-16 | Laser Biotech, Inc. | Collagen treatment apparatus |
US5304169A (en) * | 1985-09-27 | 1994-04-19 | Laser Biotech, Inc. | Method for collagen shrinkage |
US4738250A (en) * | 1985-10-01 | 1988-04-19 | Mems Technology, Incorporated | Apparatus and method for micro-electric medical stimulation of cells of living animal tissue |
US4765331A (en) * | 1987-02-10 | 1988-08-23 | Circon Corporation | Electrosurgical device with treatment arc of less than 360 degrees |
US4807620A (en) * | 1987-05-22 | 1989-02-28 | Advanced Interventional Systems, Inc. | Apparatus for thermal angioplasty |
US5143063A (en) * | 1988-02-09 | 1992-09-01 | Fellner Donald G | Method of removing adipose tissue from the body |
US5230349A (en) * | 1988-11-25 | 1993-07-27 | Sensor Electronics, Inc. | Electrical heating catheter |
AU4945490A (en) * | 1989-01-06 | 1990-08-01 | Angioplasty Systems Inc. | Electrosurgical catheter for resolving atherosclerotic plaque |
US5114423A (en) * | 1989-05-15 | 1992-05-19 | Advanced Cardiovascular Systems, Inc. | Dilatation catheter assembly with heated balloon |
US4989617A (en) * | 1989-07-14 | 1991-02-05 | Case Western Reserve University | Intramuscular electrode for neuromuscular stimulation system |
US5176135A (en) * | 1989-09-06 | 1993-01-05 | Ventritex, Inc. | Implantable defibrillation electrode system |
US5133365A (en) * | 1989-09-14 | 1992-07-28 | Cardiac Pacemakers, Inc. | Implantable tapered spiral endocardial lead for use in internal defibrillation |
US5129895A (en) * | 1990-05-16 | 1992-07-14 | Sunrise Technologies, Inc. | Laser sclerostomy procedure |
FR2671010B1 (en) * | 1990-12-27 | 1993-07-09 | Ela Medical Sa | ENDOCARDIAC PROBE PROVIDED WITH AN ACTIVE FIXING MEMBER |
NZ272209A (en) * | 1991-05-01 | 2001-02-23 | Univ Columbia | Myocardial revascularisation of the heart by a laser |
US5190517A (en) * | 1991-06-06 | 1993-03-02 | Valleylab Inc. | Electrosurgical and ultrasonic surgical system |
US5178145A (en) * | 1991-07-24 | 1993-01-12 | Rea James L | Self retaining laryngeal surface electrode and method for independent identification of human recurrent laryngeal nerve |
US5522873A (en) * | 1991-12-26 | 1996-06-04 | Webster Laboratories, Inc. | Catheter having electrode with annular recess and method of using same |
US5295955A (en) * | 1992-02-14 | 1994-03-22 | Amt, Inc. | Method and apparatus for microwave aided liposuction |
US5370677A (en) * | 1992-03-06 | 1994-12-06 | Urologix, Inc. | Gamma matched, helical dipole microwave antenna with tubular-shaped capacitor |
WO1993020768A1 (en) * | 1992-04-13 | 1993-10-28 | Ep Technologies, Inc. | Steerable microwave antenna systems for cardiac ablation |
US5314466A (en) * | 1992-04-13 | 1994-05-24 | Ep Technologies, Inc. | Articulated unidirectional microwave antenna systems for cardiac ablation |
US5261878A (en) * | 1992-05-19 | 1993-11-16 | The Regents Of The University Of California | Double balloon pediatric ductus arteriosus stent catheter and method of using the same |
US5281218A (en) * | 1992-06-05 | 1994-01-25 | Cardiac Pathways Corporation | Catheter having needle electrode for radiofrequency ablation |
US5292332A (en) * | 1992-07-27 | 1994-03-08 | Lee Benjamin I | Methods and device for percutanceous sealing of arterial puncture sites |
US5311873A (en) * | 1992-08-28 | 1994-05-17 | Ecole Polytechnique | Comparative analysis of body surface potential distribution during cardiac pacing |
CA2106126A1 (en) * | 1992-09-23 | 1994-03-24 | Ian M. Scott | Bipolar surgical instruments |
WO1994007446A1 (en) * | 1992-10-05 | 1994-04-14 | Boston Scientific Corporation | Device and method for heating tissue |
US5300065A (en) * | 1992-11-06 | 1994-04-05 | Proclosure Inc. | Method and apparatus for simultaneously holding and sealing tissue |
US5558671A (en) * | 1993-07-22 | 1996-09-24 | Yates; David C. | Impedance feedback monitor for electrosurgical instrument |
US5498260A (en) * | 1993-02-08 | 1996-03-12 | Xintec Corporation | Internal reflectance angle firing fiber optic laser delivery device and method of use |
US5454807A (en) * | 1993-05-14 | 1995-10-03 | Boston Scientific Corporation | Medical treatment of deeply seated tissue using optical radiation |
US5405346A (en) * | 1993-05-14 | 1995-04-11 | Fidus Medical Technology Corporation | Tunable microwave ablation catheter |
US5431649A (en) * | 1993-08-27 | 1995-07-11 | Medtronic, Inc. | Method and apparatus for R-F ablation |
US5437664A (en) * | 1994-01-18 | 1995-08-01 | Endovascular, Inc. | Apparatus and method for venous ligation |
US5571216A (en) * | 1994-01-19 | 1996-11-05 | The General Hospital Corporation | Methods and apparatus for joining collagen-containing materials |
US5447529A (en) * | 1994-01-28 | 1995-09-05 | Philadelphia Heart Institute | Method of using endocardial impedance for determining electrode-tissue contact, appropriate sites for arrhythmia ablation and tissue heating during ablation |
US5462545A (en) * | 1994-01-31 | 1995-10-31 | New England Medical Center Hospitals, Inc. | Catheter electrodes |
US5458596A (en) * | 1994-05-06 | 1995-10-17 | Dorsal Orthopedic Corporation | Method and apparatus for controlled contraction of soft tissue |
US5529067A (en) * | 1994-08-19 | 1996-06-25 | Novoste Corporation | Methods for procedures related to the electrophysiology of the heart |
US5591157A (en) * | 1994-09-07 | 1997-01-07 | Hennings; David R. | Method and apparatus for tympanic membrane shrinkage |
US5662643A (en) * | 1994-09-28 | 1997-09-02 | Abiomed R & D, Inc. | Laser welding system |
US5549640A (en) * | 1995-06-08 | 1996-08-27 | Fontenot; Mark G. | Device and method for enhancement of wound healing |
JP2002511774A (en) * | 1996-07-28 | 2002-04-16 | バイオセンス・インコーポレイテッド | Electromagnetic heart biostimulation |
US5752518A (en) * | 1996-10-28 | 1998-05-19 | Ep Technologies, Inc. | Systems and methods for visualizing interior regions of the body |
-
1996
- 1996-12-08 US US08/768,607 patent/US6071303A/en not_active Expired - Lifetime
-
1997
- 1997-12-12 WO PCT/US1997/022140 patent/WO1998026738A1/en not_active Application Discontinuation
- 1997-12-12 JP JP52775798A patent/JP2002515795A/en active Pending
- 1997-12-12 EP EP97954042A patent/EP0963185A4/en not_active Withdrawn
- 1997-12-12 CA CA002275688A patent/CA2275688A1/en not_active Abandoned
- 1997-12-12 BR BR9714947-0A patent/BR9714947A/en not_active Application Discontinuation
- 1997-12-12 AU AU57920/98A patent/AU5792098A/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5246438A (en) | 1988-11-25 | 1993-09-21 | Sensor Electronics, Inc. | Method of radiofrequency ablation |
US5323781A (en) * | 1992-01-31 | 1994-06-28 | Duke University | Methods for the diagnosis and ablation treatment of ventricular tachycardia |
US5551427A (en) * | 1995-02-13 | 1996-09-03 | Altman; Peter A. | Implantable device for the effective elimination of cardiac arrhythmogenic sites |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6406420B1 (en) | 1997-01-02 | 2002-06-18 | Myocor, Inc. | Methods and devices for improving cardiac function in hearts |
US6050936A (en) * | 1997-01-02 | 2000-04-18 | Myocor, Inc. | Heart wall tension reduction apparatus |
US6059715A (en) * | 1997-01-02 | 2000-05-09 | Myocor, Inc. | Heart wall tension reduction apparatus |
US6162168A (en) * | 1997-01-02 | 2000-12-19 | Myocor, Inc. | Heart wall tension reduction apparatus |
US6165120A (en) * | 1997-01-02 | 2000-12-26 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US6165119A (en) * | 1997-01-02 | 2000-12-26 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US6629921B1 (en) | 1997-01-02 | 2003-10-07 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US6261222B1 (en) | 1997-01-02 | 2001-07-17 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US6045497A (en) * | 1997-01-02 | 2000-04-04 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US6332864B1 (en) | 1997-01-02 | 2001-12-25 | Myocor, Inc. | Heart wall tension reduction apparatus |
US6332863B1 (en) | 1997-01-02 | 2001-12-25 | Myocor, Inc. | Heart wall tension reduction kit |
US8226711B2 (en) | 1997-12-17 | 2012-07-24 | Edwards Lifesciences, Llc | Valve to myocardium tension members device and method |
US6332893B1 (en) | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
US6402680B2 (en) | 1998-07-29 | 2002-06-11 | Myocor, Inc. | Stress reduction apparatus and method |
US6264602B1 (en) | 1998-07-29 | 2001-07-24 | Myocor, Inc. | Stress reduction apparatus and method |
US6260552B1 (en) | 1998-07-29 | 2001-07-17 | Myocor, Inc. | Transventricular implant tools and devices |
US7981020B2 (en) | 1998-07-29 | 2011-07-19 | Edwards Lifesciences Llc | Transventricular implant tools and devices |
US6402679B1 (en) | 1998-09-21 | 2002-06-11 | Myocor, Inc. | External stress reduction device and method |
US8579798B2 (en) | 1998-09-21 | 2013-11-12 | Edwards Lifesciences, Llc | External cardiac stress reduction method |
US6183411B1 (en) | 1998-09-21 | 2001-02-06 | Myocor, Inc. | External stress reduction device and method |
US6355030B1 (en) | 1998-09-25 | 2002-03-12 | Cardiothoracic Systems, Inc. | Instruments and methods employing thermal energy for the repair and replacement of cardiac valves |
JP2004512859A (en) * | 2000-04-27 | 2004-04-30 | アトリキュア インコーポレイテッド | Transmural cutting device and method |
US6343605B1 (en) | 2000-08-08 | 2002-02-05 | Scimed Life Systems, Inc. | Percutaneous transluminal myocardial implantation device and method |
US9198757B2 (en) | 2000-10-06 | 2015-12-01 | Edwards Lifesciences, Llc | Methods and devices for improving mitral valve function |
US7766812B2 (en) | 2000-10-06 | 2010-08-03 | Edwards Lifesciences Llc | Methods and devices for improving mitral valve function |
US6622730B2 (en) | 2001-03-30 | 2003-09-23 | Myocor, Inc. | Device for marking and aligning positions on the heart |
US8092367B2 (en) | 2001-09-07 | 2012-01-10 | Mardil, Inc. | Method for external stabilization of the base of the heart |
US8128553B2 (en) | 2001-09-07 | 2012-03-06 | Mardil, Inc. | Method and apparatus for external stabilization of the heart |
US9289298B2 (en) | 2001-09-07 | 2016-03-22 | Mardil, Inc. | Method and apparatus for external stabilization of the heart |
US8070805B2 (en) | 2002-01-09 | 2011-12-06 | Edwards Lifesciences Llc | Devices and methods for heart valve treatment |
US7678145B2 (en) | 2002-01-09 | 2010-03-16 | Edwards Lifesciences Llc | Devices and methods for heart valve treatment |
US7666224B2 (en) | 2002-11-12 | 2010-02-23 | Edwards Lifesciences Llc | Devices and methods for heart valve treatment |
US10463886B2 (en) | 2007-02-22 | 2019-11-05 | Ramot At Tel-Aviv University Ltd. | Treating weakened vessel wall such as vulnerable plaque or aneurysms |
Also Published As
Publication number | Publication date |
---|---|
CA2275688A1 (en) | 1998-06-25 |
AU5792098A (en) | 1998-07-15 |
EP0963185A4 (en) | 2000-05-24 |
EP0963185A1 (en) | 1999-12-15 |
US6071303A (en) | 2000-06-06 |
JP2002515795A (en) | 2002-05-28 |
BR9714947A (en) | 2001-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6071303A (en) | Device for the treatment of infarcted tissue and method of treating infarcted tissue | |
US5928224A (en) | Device for the treatment of damaged heart valve leaflets and methods of using the device | |
US7128740B2 (en) | Method for interrupting conduction paths within the heart | |
US6695838B2 (en) | System and method for performing cardiac tissue ablation | |
JP4636683B2 (en) | Soft tissue coagulation probe | |
US8623010B2 (en) | Cardiac mapping instrument with shapeable electrode | |
US6837885B2 (en) | Surgical probe for supporting inflatable therapeutic devices in contact with tissue in or around body orifices and within tumors | |
WO2003063717A1 (en) | System and method of performing an electrosurgical procedure | |
WO1998018393A1 (en) | Device for the treatment of patent ductus arteriosus and method of using the device | |
WO2016127162A1 (en) | Radio-frequency electrical membrane breakdown for the treatment of cardiac rhythm disorders and for renal neuromodulation | |
US10441347B2 (en) | Adaptive electrode for bi-polar ablation | |
US6152139A (en) | Device and method for preparing veins | |
JPH0838503A (en) | Catheter apparatus fitted wih gage-shaped electrode for ablation | |
JP2002301087A (en) | Balloon catheter for multipurpose ablation | |
MXPA99005713A (en) | Device for the treatment of infarcted tissue and method of using the device | |
CN1240341A (en) | Device for the treatment of infarcted tissue and method of using the device | |
Dunkin et al. | Thermal Methods to |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 97180773.6 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
CFP | Corrected version of a pamphlet front page |
Free format text: ADD INID NUMBER (63) "RELATED BY CONTINUATION (CON) OR CONTINUATION-IN-PART (CIP) TO EARLIER APPLICATION" WHICH WAS INADVERTENTLY OMITTED FROM THE FRONT PAGE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1997954042 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 57920/98 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2275688 Country of ref document: CA Ref document number: 2275688 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1999/005713 Country of ref document: MX |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1997954042 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997954042 Country of ref document: EP |